These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 29096671)

  • 1. Community-led Responses for Elimination (CoRE): a study protocol for a community randomized controlled trial assessing the effectiveness of community-level, reactive focal drug administration for reducing Plasmodium falciparum infection prevalence and incidence in Southern Province, Zambia.
    Bridges DJ; Miller JM; Chalwe V; Moonga H; Hamainza B; Steketee R; Silumbe K; Nyangu J; Larsen DA
    Trials; 2017 Nov; 18(1):511. PubMed ID: 29096671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence in Southern Province, Zambia: study protocol for a community randomized controlled trial.
    Eisele TP; Silumbe K; Finn T; Chalwe V; Kamuliwo M; Hamainza B; Moonga H; Bennett A; Yukich J; Keating J; Steketee RW; Miller JM
    Trials; 2015 Aug; 16():347. PubMed ID: 26268804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children.
    Nambozi M; Van Geertruyden JP; Hachizovu S; Chaponda M; Mukwamataba D; Mulenga M; Ubben D; D'Alessandro U
    Malar J; 2011 Feb; 10():50. PubMed ID: 21352609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cluster-randomized trial of monthly malaria prophylaxis versus focused screening and treatment: a study protocol to define malaria elimination strategies in Cambodia.
    Manning J; Lon C; Spring M; Wojnarski M; Somethy S; Chann S; Gosi P; Soveasna K; Sriwichai S; Kuntawunginn W; Fukuda MM; Smith PL; Rekol H; Sinoun M; So M; Lin J; Satharath P; Saunders D
    Trials; 2018 Oct; 19(1):558. PubMed ID: 30326952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.
    Yavo W; Faye B; Kuete T; Djohan V; Oga SA; Kassi RR; Diatta M; Ama MV; Tine R; Ndiaye JL; Evi JB; Same-Ekobo A; Faye O; Koné M
    Malar J; 2011 Jul; 10():198. PubMed ID: 21774826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study.
    Ogutu BR; Onyango KO; Koskei N; Omondi EK; Ongecha JM; Otieno GA; Obonyo C; Otieno L; Eyase F; Johnson JD; Omollo R; Perkins DJ; Akhwale W; Juma E
    Malar J; 2014 Jan; 13():33. PubMed ID: 24472156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
    Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
    Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the efficacy and tolerability of dihydroartemisinin-piperaquine-trimethoprim versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal.
    Menan H; Faye O; Same-Ekobo A; Oga AS; Faye B; Kiki Barro CP; Kuete T; N'diaye JL; Vicky AM; Tine R; Yavo W; Kane D; Kassi KF; Kone M
    Malar J; 2011 Jul; 10():185. PubMed ID: 21740570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term Impact of Mass Drug Administration With Dihydroartemisinin Plus Piperaquine on Malaria in Southern Province Zambia: A Cluster-Randomized Controlled Trial.
    Eisele TP; Bennett A; Silumbe K; Finn TP; Chalwe V; Kamuliwo M; Hamainza B; Moonga H; Kooma E; Chizema Kawesha E; Yukich J; Keating J; Porter T; Conner RO; Earle D; Steketee RW; Miller JM
    J Infect Dis; 2016 Dec; 214(12):1831-1839. PubMed ID: 27923947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis.
    Kern SE; Tiono AB; Makanga M; Gbadoé AD; Premji Z; Gaye O; Sagara I; Ubben D; Cousin M; Oladiran F; Sander O; Ogutu B
    Malar J; 2011 Jul; 10():210. PubMed ID: 21801345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.
    Gerardin J; Eckhoff P; Wenger EA
    BMC Infect Dis; 2015 Mar; 15():144. PubMed ID: 25887935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to Mass Drug Administration with Dihydroartemisinin-Piperaquine and
    Finn TP; Porter TR; Moonga H; Silumbe K; Daniels RF; Volkman SK; Yukich JO; Keating J; Bennett A; Steketee RW; Miller JM; Eisele TP
    Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):37-45. PubMed ID: 32618267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open-label trial with artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria three years after its broad introduction in Jimma Zone, Ethiopia.
    Eshetu T; Abdo N; Bedru KH; Fekadu S; Wieser A; Pritsch M; Löscher T; Berens-Riha N
    Malar J; 2012 Jul; 11():240. PubMed ID: 22824059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Focal Mass Drug Administration and Mass Drug Administration with Dihydroartemisinin-Piperaquine for Malaria Prevention in Southern Province, Zambia: Results of a Community-Randomized Controlled Trial.
    Yukich JO; Scott C; Silumbe K; Larson BA; Bennett A; Finn TP; Hamainza B; Conner RO; Porter TR; Keating J; Steketee RW; Eisele TP; Miller JM
    Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):46-53. PubMed ID: 32618249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria.
    Muhindo MK; Kakuru A; Jagannathan P; Talisuna A; Osilo E; Orukan F; Arinaitwe E; Tappero JW; Kaharuza F; Kamya MR; Dorsey G
    Malar J; 2014 Jan; 13():32. PubMed ID: 24468007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
    Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
    Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos.
    Mayxay M; Khanthavong M; Chanthongthip O; Imwong M; Pongvongsa T; Hongvanthong B; Phompida S; Vanisaveth V; White NJ; Newton PN
    Malar J; 2012 Jun; 11():184. PubMed ID: 22681769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
    Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I
    Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study protocol for a cluster randomised controlled factorial design trial to assess the effectiveness and feasibility of reactive focal mass drug administration and vector control to reduce malaria transmission in the low endemic setting of Namibia.
    Medzihradsky OF; Kleinschmidt I; Mumbengegwi D; Roberts KW; McCreesh P; Dufour MK; Uusiku P; Katokele S; Bennett A; Smith J; Sturrock H; Prach LM; Ntuku H; Tambo M; Didier B; Greenhouse B; Gani Z; Aerts A; Gosling R; Hsiang MS
    BMJ Open; 2018 Jan; 8(1):e019294. PubMed ID: 29374672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.